Latilactobacillus sakei
Selected indexed studies
- Latilactobacillus sakei: a candidate probiotic with a key role in food fermentations and health promotion. (Crit Rev Food Sci Nutr, 2024) [PMID:35997270]
- Latilactobacillus sakei LB-P12 Ameliorates Osteoarthritis by Reducing Cartilage Degradation and Inflammation via Regulation of NF-κB/HIF-2α Pathway. (J Microbiol Biotechnol, 2025) [PMID:40329628]
- Latilactobacillus sakei Furu2019 and stachyose as probiotics, prebiotics, and synbiotics alleviate constipation in mice. (Front Nutr, 2022) [PMID:36687730]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Latilactobacillus sakei: a candidate probiotic with a key role in food fermentations and health promotion. (2024) pubmed
- Latilactobacillus sakei LB-P12 Ameliorates Osteoarthritis by Reducing Cartilage Degradation and Inflammation via Regulation of NF-κB/HIF-2α Pathway. (2025) pubmed
- Latilactobacillus sakei Furu2019 and stachyose as probiotics, prebiotics, and synbiotics alleviate constipation in mice. (2022) pubmed
- Classification of Latilactobacillus sakei subspecies based on MALDI-TOF MS protein profiles using machine learning models. (2024) pubmed
- Heat-Treated Paraprobiotic Latilactobacillus sakei KU15041 and Latilactobacillus curvatus KU15003 Show an Antioxidant and Immunostimulatory Effect. (2024) pubmed
- Latilactobacillus sakei QC9 alleviates hyperglycaemia in high-fat diet and streptozotocin-induced type 2 diabetes mellitus mice via the microbiota-gut-liver axis. (2024) pubmed
- Latilactobacillus sakei Wikim0066 Protects Skin through MMP Regulation on UVB-Irradiated In Vitro and In Vivo Model. (2023) pubmed
- A New Bacteriocin from Latilactobacillus sakei: In vitro and In situ Application. (2023) pubmed
- Latilactobacillus sakei WIKIM31 Decelerates Weight Gain in High-Fat Diet-Induced Obese Mice by Modulating Lipid Metabolism and Suppressing Inflammation. (2021) pubmed
- Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis: an exploratory randomized, double-blind, placebo-controlled clinical trial. (2025) pubmed